With our functional in vitro studies, we demonstrated that in the presence of immobilized target antigens, CAR T products rich in effector memory T cells secreted higher amounts of IFNγ and IL-2, and induced more potent CAR-specific anti-tumor activity. The gene discussed is IFNG; the disease is neoplasm.